United States

Gracell Biotechnologies Inc.

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
William Cao Wei Officer; CHIEF EXECUTIVE OFFICER Officer
Transaction date
Proposed sale
Price
329.97
Quantity 19,946
Value US$4,416,609
TLS Beta Pte. Ltd. Shareholder
Transaction date
Proposed sale
Price
198.08
Quantity 76,065
Value US$4,584,059
William Cao Wei Officer; CHIEF EXECUTIVE OFFICER Officer
Transaction date
Proposed sale
Price
54.40
Quantity 73,026
Value US$496,706
GRACELL VENTURE HOLDINGS LIMITED Director; 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
3.92
Quantity 73,612
Value US$288,235
GRACELL VENTURE HOLDINGS LIMITED Director; 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.03
Quantity 85,233
Value US$428,543
William Cao Wei Officer; Chief Executive Officer Officer
Transaction date
Proposed sale
Price
1.87
Quantity 594,738
Value US$1,112,160
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-21 2023-11-21 PrS Proposed sale
William Cao Wei

Officer; CHIEF EXECUTIVE OFFICER

Officer
19,946
329.97
US$4,416,609 		19,946 329.97 US$4,416,609
2023-10-12 2023-10-12 PrS Proposed sale
TLS Beta Pte. Ltd.

Shareholder
76,065
198.08
US$4,584,059 		76,065 198.08 US$4,584,059
2023-08-23 2023-08-23 PrS Proposed sale
William Cao Wei

Officer; CHIEF EXECUTIVE OFFICER

Officer
73,026
54.40
US$496,706 		73,026 54.40 US$496,706
2023-06-20 2023-06-20 PrS Proposed sale
GRACELL VENTURE HOLDINGS LIMITED

Director; 10% Stockholder

Non-Executive Director Large shareholder
73,612
3.92
US$288,235 		73,612 3.92 US$288,235
2023-06-16 2023-06-16 PrS Proposed sale
GRACELL VENTURE HOLDINGS LIMITED

Director; 10% Stockholder

Non-Executive Director Large shareholder
85,233
5.03
US$428,543 		85,233 5.03 US$428,543
2023-06-15 2023-06-15 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
116,000
5.73
US$664,680 		116,000 5.73 US$664,680
2023-06-15 2023-06-15 PrS Proposed sale
OrbiMed Partners Master Fund Limited

Shareholder
205,000
5.73
US$1,174,650 		205,000 5.73 US$1,174,650
2023-06-15 2023-06-15 PrS Proposed sale
2.6
OrbiMed New Horizons Master Fund, L.P.

Shareholder
305,748
5.73
US$1,751,936 		305,748 5.73 US$1,751,936
2023-04-13 2023-04-13 PrS Proposed sale
William Cao Wei

Officer; Chief Executive Officer

Officer
594,738
1.87
US$1,112,160 		594,738 1.87 US$1,112,160
Explore more

More insider trading research around Gracell Biotechnologies Inc.

More insider trades in United States
Insider trading in North America